Sankyo Pharma Inc. Release: U.S. Subsidiaries Join Together To Form Daiichi Sankyo, Inc.
4/3/2006 11:03:22 AM
More...
|
Sankyo Pharma Inc. Release: First Data To Show Addition Of A Bile Acid Sequestrant (WelChol, colesevelam HCl) To Statin Therapy Significantly Reduces Median Hs-CRP Levels
11/15/2005 11:30:36 AM
More...
|
Sankyo Pharma Inc. Halts Development Of Pactimibe (CS-505)
10/26/2005 12:06:24 PM
More...
|
Sankyo Pharma Inc. Release: New Study Finds Additional LDL-C Drops When WelChol(R) (colesevelam HCl) Is Added To Fenofibrate In Patients With Mixed Hyperlipidemia
10/19/2005 5:13:18 PM
More...
|
Daiichi Pharmaceutical (JPN), Sankyo Company, Ltd. (SKXOF.PK) Sign Basic Agreement To Integrate Businesses
10/19/2005 5:12:51 PM
More...
|
Sankyo Pharma Inc. Release: New Study Demonstrates Co-Administration Of WelChol(R) (colesevelam HCI) And TriCor(R) (fenofibrate tablets) Resulted In No Significant Drug-Drug Interactions
10/19/2005 5:11:50 PM
More...
|
Kirin Brewery Co., Ltd. (KNBWY) , Sankyo Company, Ltd. (SKXOF.PK) To Terminate Joint Marketing Of Renal Anemia Drug ESPO And Leukopenia Drug GRAN By Next March
10/19/2005 5:11:50 PM
More...
|
Sankyo Pharma Inc. Release: New Data Demonstrates That BENICAR And BENICAR HCT Achieve JNC 7 Blood Pressure Goals
10/19/2005 5:11:31 PM
More...
|
Dendrite International, Inc. (DRTE) Awarded Sales And Marketing Data Outsourcing Contract From Sankyo Pharma Inc.
10/19/2005 5:10:52 PM
More...
|
Forest Laboratories, Inc. (FRX) Announces That Neramexane Did Not Demonstrate Statistical Significance In Recently Completed Phase III Trial In Patients With Moderate To Severe Alzheimer's Disease
10/19/2005 5:10:29 PM
More...
|
|